154 related articles for article (PubMed ID: 3280726)
1. p53 in chronic myelogenous leukemia. Study of mechanisms of differential expression.
Lübbert M; Miller CW; Crawford L; Koeffler HP
J Exp Med; 1988 Mar; 167(3):873-86. PubMed ID: 3280726
[TBL] [Abstract][Full Text] [Related]
2. [Down-regulation of transcription factor PU.1 via abnormal epigenetic modification in chronic myeloid leukemia].
Yang H; Yan JS; Tao R; Hao SG; Liang H; Ma LY
Zhonghua Zhong Liu Za Zhi; 2012 Mar; 34(3):169-75. PubMed ID: 22780968
[TBL] [Abstract][Full Text] [Related]
3. [Molecular analysis of transformation into blast crisis in chronic myelogenous leukemia].
Okabe M
Hokkaido Igaku Zasshi; 1993 Mar; 68(2):237-50. PubMed ID: 8509066
[TBL] [Abstract][Full Text] [Related]
4. p53 in chronic myeloid leukemia cell lines.
Bi S; Hughes T; Bungey J; Chase A; de Fabritiis P; Goldman JM
Leukemia; 1992 Aug; 6(8):839-42. PubMed ID: 1640738
[TBL] [Abstract][Full Text] [Related]
5. Activation of EVI1 transcription by the LEF1/β-catenin complex with p53-alteration in myeloid blast crisis of chronic myeloid leukemia.
Manachai N; Saito Y; Nakahata S; Bahirvani AG; Osato M; Morishita K
Biochem Biophys Res Commun; 2017 Jan; 482(4):994-1000. PubMed ID: 27908728
[TBL] [Abstract][Full Text] [Related]
6. JunB gene expression is inactivated by methylation in chronic myeloid leukemia.
Yang MY; Liu TC; Chang JG; Lin PM; Lin SF
Blood; 2003 Apr; 101(8):3205-11. PubMed ID: 12506033
[TBL] [Abstract][Full Text] [Related]
7. The abnormal p53 proteins expressed in CML cell lines are non-functional.
Bi S; Lanza F; Goldman JM
Leukemia; 1993 Nov; 7(11):1840-5. PubMed ID: 8231251
[TBL] [Abstract][Full Text] [Related]
8. Analysis of P210bcr-abl tyrosine protein kinase activity in various subtypes of Philadelphia chromosome-positive cells from chronic myelogenous leukemia patients.
Maxwell SA; Kurzrock R; Parsons SJ; Talpaz M; Gallick GE; Kloetzer WS; Arlinghaus RB; Kouttab NM; Keating MJ; Gutterman JU
Cancer Res; 1987 Mar; 47(6):1731-9. PubMed ID: 2434223
[TBL] [Abstract][Full Text] [Related]
9. Gene structure, promoter activity, and chromosomal location of the DR-nm23 gene, a related member of the nm23 gene family.
Martinez R; Venturelli D; Perrotti D; Veronese ML; Kastury K; Druck T; Huebner K; Calabretta B
Cancer Res; 1997 Mar; 57(6):1180-7. PubMed ID: 9067290
[TBL] [Abstract][Full Text] [Related]
10. Expression of differentially phosphorylated Rb and mutant p53 proteins in myeloid leukemia cell lines.
Sen S; Takahashi R; Rani S; Freireich EJ; Stass SA
Leuk Res; 1993 Aug; 17(8):639-47. PubMed ID: 8355507
[TBL] [Abstract][Full Text] [Related]
11. The spectrum of molecular alterations in the evolution of chronic myelocytic leukemia.
Ahuja H; Bar-Eli M; Arlin Z; Advani S; Allen SL; Goldman J; Snyder D; Foti A; Cline M
J Clin Invest; 1991 Jun; 87(6):2042-7. PubMed ID: 2040694
[TBL] [Abstract][Full Text] [Related]
12. Polymorphism of the human c-abl gene: relation to incidence and course of chronic myelogenous leukemia.
Daniel L; Ahmed CM; Bloodgood RS; Kidd JR; Castiglione CM; Duttagupta S; Lebowitz P
Oncogene; 1987 May; 1(2):193-200. PubMed ID: 2894000
[TBL] [Abstract][Full Text] [Related]
13. Biphenotypic blast crisis of chronic myelogenous leukemia: abnormalities of p53 and retinoblastoma genes.
Ishikura H; Yufu Y; Yamashita S; Abe Y; Okamura T; Motomura S; Nishimura J; Nawata H
Leuk Lymphoma; 1997 May; 25(5-6):573-8. PubMed ID: 9250829
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneity in expression of the bcr-abl fusion transcript in CML blast crisis.
Andrews DF; Collins SJ
Leukemia; 1987 Oct; 1(10):718-24. PubMed ID: 3312834
[TBL] [Abstract][Full Text] [Related]
15. Detailed mapping of methylcytosine positions at the CpG island surrounding the Pa promoter at the bcr-abl locus in CML patients and in two cell lines, K562 and BV173.
Fajkusová L; Fajkus J; Polácková K; Fulnecek J; Dvoráková D; Krahulcová E
Blood Cells Mol Dis; 2000 Jun; 26(3):193-204. PubMed ID: 10950939
[TBL] [Abstract][Full Text] [Related]
16. Establishment and characterization of a new Ph1-positive chronic myeloid leukemia cell line MC3 with trilineage phenotype and an altered p53 gene.
Okabe M; Kunieda Y; Nakane S; Kurosawa M; Itaya T; Vogler WR; Shoji M; Miyazaki T
Leuk Lymphoma; 1995 Feb; 16(5-6):493-503. PubMed ID: 7787756
[TBL] [Abstract][Full Text] [Related]
17. [Differential analysis of BM cell morphology, immunophenotypic, cytogenetic characters and prognosis between myeloblastic and lymphoblastic crisis of CML].
Liu YL; Wang XN; Liu HS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):629-33. PubMed ID: 24989266
[TBL] [Abstract][Full Text] [Related]
18. Expression of nuclear envelope lamins A and C in human myeloid leukemias.
Kaufmann SH
Cancer Res; 1992 May; 52(10):2847-53. PubMed ID: 1581898
[TBL] [Abstract][Full Text] [Related]
19. Translational regulation of human p53 gene expression.
Fu L; Minden MD; Benchimol S
EMBO J; 1996 Aug; 15(16):4392-401. PubMed ID: 8861966
[TBL] [Abstract][Full Text] [Related]
20. Cell lines and peripheral blood leukocytes derived from individuals with chronic myelogenous leukemia display virtually identical proteins phosphorylated on tyrosine residues.
Huhn RD; Posner MR; Rayter SI; Foulkes JG; Frackelton AR
Proc Natl Acad Sci U S A; 1987 Jul; 84(13):4408-12. PubMed ID: 2440021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
